459 Studies Now Enrolling
A Natural History Study to Observe Disease Progression, Standard of Care and Investigate Biomarkers in Alport Syndrome Patients
A study to observe disease progression and care of patients with Alport Syndrome
| Sponsor: | Regulus Therapeutics Inc. |
| Enrolling: | Male and Female Patients |
| Clinic Visits: | 20 |
| IRB Number: | AAAO1861 |
| U.S. Govt. ID: | NCT02136862 |
| Contact: | Gerald Appel: 212-305-0320 / gba2@columbia.edu |
Additional Study Information:
The purpose of this research study is to understand the way Alport Syndrome affects patients kidneys over time. Alport syndrome is a genetic condition that causes damage to your kidneys over time. Currently there is not much information on the disease. Information about how the body is affected by the disease will be collected, along with medical and family history.
This study is closed
